Literature DB >> 28401956

Prostate cancer: Peptidomimetics have potential.

Louise Stone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28401956     DOI: 10.1038/nrurol.2017.59

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer.

Authors:  Xiaoju Wang; Yuanyuan Qiao; Irfan A Asangani; Bushra Ateeq; Anton Poliakov; Marcin Cieślik; Sethuramasundaram Pitchiaya; Balabhadrapatruni V S K Chakravarthi; Xuhong Cao; Xiaojun Jing; Cynthia X Wang; Ingrid J Apel; Rui Wang; Jean Ching-Yi Tien; Kristin M Juckette; Wei Yan; Hui Jiang; Shaomeng Wang; Sooryanarayana Varambally; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2017-03-23       Impact factor: 31.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.